ArticleFrontiers in cardiovascular medicine2022

Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy.

Yangbo Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.